IVX 20.0% 0.2¢ invion limited

financial position and lupus study inv103, page-3

  1. 668 Posts.
    lightbulb Created with Sketch. 9
    Has the company given any indication that they r not going to release interim results? They must be confident of the ability to establish a deal if they r not going to release results, because if they needed to do a capital raising the release of positive results would provide the pump in share price needed.

    Like others have said on here previously, there's R & D money to come in, and the possibility of a favourable court trial bringing more money.

    Anyway, at these prices it's good buying! IMO
 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.